Quality of life assessment in dogs and cats receiving chemotherapy: a review of current methods

Research output: Contribution to journalReviewResearchpeer-review

Standard

Quality of life assessment in dogs and cats receiving chemotherapy : a review of current methods. / Vøls, Kåre Kryger; Heden, Martin Anker; Kristensen, Annemarie Thuri; Sandøe, Peter.

In: Veterinary and Comparative Oncology, Vol. 15, No. 3, 2017, p. 684–691.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Vøls, KK, Heden, MA, Kristensen, AT & Sandøe, P 2017, 'Quality of life assessment in dogs and cats receiving chemotherapy: a review of current methods', Veterinary and Comparative Oncology, vol. 15, no. 3, pp. 684–691. https://doi.org/10.1111/vco.12242

APA

Vøls, K. K., Heden, M. A., Kristensen, A. T., & Sandøe, P. (2017). Quality of life assessment in dogs and cats receiving chemotherapy: a review of current methods. Veterinary and Comparative Oncology, 15(3), 684–691. https://doi.org/10.1111/vco.12242

Vancouver

Vøls KK, Heden MA, Kristensen AT, Sandøe P. Quality of life assessment in dogs and cats receiving chemotherapy: a review of current methods. Veterinary and Comparative Oncology. 2017;15(3):684–691. https://doi.org/10.1111/vco.12242

Author

Vøls, Kåre Kryger ; Heden, Martin Anker ; Kristensen, Annemarie Thuri ; Sandøe, Peter. / Quality of life assessment in dogs and cats receiving chemotherapy : a review of current methods. In: Veterinary and Comparative Oncology. 2017 ; Vol. 15, No. 3. pp. 684–691.

Bibtex

@article{ba6cee32526b41de8b2b2a9f930269b4,
title = "Quality of life assessment in dogs and cats receiving chemotherapy: a review of current methods",
abstract = "This study aimed to review currently reported methods of assessing the effects of chemotherapy on the quality of life (QoL) of canine and feline patients and to explore novel ways to assess QoL in such patients in the light of the experience to date in human pediatric oncology. A qualitative comparative analysis of published papers on the effects of chemotherapy on QoL in dogs and cats were conducted. This was supplemented with a comparison of the parameters and domains used in veterinary QoL-assessments with those used in the Pediatric Quality of Life Inventory (PedsQL{\texttrademark}) questionnaire designed to assess QoL in toddlers. Each of the identified publications including QoL-assessment in dogs and cats receiving chemotherapy applied a different method of QoL-assessment. In addition, the veterinary QoL-assessments were mainly focused on physical clinical parameters, whereas the emotional (6/11), social (4/11) and role (4/11) domains were less represented. QoL-assessment of cats and dogs receiving chemotherapy is in its infancy. The most commonly reported method to assess QoL was questionnaire based and mostly included physical and clinical parameters. Standardizing and including a complete range of potentially relevant parameters in future QoL assessments may benefit owner decision making.",
author = "V{\o}ls, {K{\aa}re Kryger} and Heden, {Martin Anker} and Kristensen, {Annemarie Thuri} and Peter Sand{\o}e",
year = "2017",
doi = "10.1111/vco.12242",
language = "English",
volume = "15",
pages = "684–691",
journal = "Veterinary and Comparative Oncology",
issn = "1476-5810",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Quality of life assessment in dogs and cats receiving chemotherapy

T2 - a review of current methods

AU - Vøls, Kåre Kryger

AU - Heden, Martin Anker

AU - Kristensen, Annemarie Thuri

AU - Sandøe, Peter

PY - 2017

Y1 - 2017

N2 - This study aimed to review currently reported methods of assessing the effects of chemotherapy on the quality of life (QoL) of canine and feline patients and to explore novel ways to assess QoL in such patients in the light of the experience to date in human pediatric oncology. A qualitative comparative analysis of published papers on the effects of chemotherapy on QoL in dogs and cats were conducted. This was supplemented with a comparison of the parameters and domains used in veterinary QoL-assessments with those used in the Pediatric Quality of Life Inventory (PedsQL™) questionnaire designed to assess QoL in toddlers. Each of the identified publications including QoL-assessment in dogs and cats receiving chemotherapy applied a different method of QoL-assessment. In addition, the veterinary QoL-assessments were mainly focused on physical clinical parameters, whereas the emotional (6/11), social (4/11) and role (4/11) domains were less represented. QoL-assessment of cats and dogs receiving chemotherapy is in its infancy. The most commonly reported method to assess QoL was questionnaire based and mostly included physical and clinical parameters. Standardizing and including a complete range of potentially relevant parameters in future QoL assessments may benefit owner decision making.

AB - This study aimed to review currently reported methods of assessing the effects of chemotherapy on the quality of life (QoL) of canine and feline patients and to explore novel ways to assess QoL in such patients in the light of the experience to date in human pediatric oncology. A qualitative comparative analysis of published papers on the effects of chemotherapy on QoL in dogs and cats were conducted. This was supplemented with a comparison of the parameters and domains used in veterinary QoL-assessments with those used in the Pediatric Quality of Life Inventory (PedsQL™) questionnaire designed to assess QoL in toddlers. Each of the identified publications including QoL-assessment in dogs and cats receiving chemotherapy applied a different method of QoL-assessment. In addition, the veterinary QoL-assessments were mainly focused on physical clinical parameters, whereas the emotional (6/11), social (4/11) and role (4/11) domains were less represented. QoL-assessment of cats and dogs receiving chemotherapy is in its infancy. The most commonly reported method to assess QoL was questionnaire based and mostly included physical and clinical parameters. Standardizing and including a complete range of potentially relevant parameters in future QoL assessments may benefit owner decision making.

U2 - 10.1111/vco.12242

DO - 10.1111/vco.12242

M3 - Review

C2 - 27140826

VL - 15

SP - 684

EP - 691

JO - Veterinary and Comparative Oncology

JF - Veterinary and Comparative Oncology

SN - 1476-5810

IS - 3

ER -

ID: 161241303